scholarly journals Percutaenous renal tumour ablation

2020 ◽  
Author(s):  
David Luong ◽  
Yuranga Weerakkody
Keyword(s):  
Author(s):  
Stephen Faddegon ◽  
Ephrem O. Olweny ◽  
Jeffrey A. Cadeddu

Nearly two-thirds of newly detected renal masses are clinical stage 1, with T1a tumours accounting for 60% of the newly detected stage 1 tumours. Guideline panels convened by the American Urological Association and the European Association of Urology recommend nephron-sparing surgery as the gold standard treatment for small renal masses, with active surveillance and thermal ablation recommended as alternative strategies in select patients. However, there is a dearth of studies directly comparing outcomes for energy-based ablation to those for traditional surgical treatments for small renal masses, and future prospective randomized trials will be invaluable in this regard. Ongoing research in renal tumour ablation targets several areas, including but not limited to achieving larger ablation sizes, decreasing morbidity, and development of novel technologies for renal tumour ablation.


2010 ◽  
Vol 107 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Ellen M. Kerkhof ◽  
Bas W. Raaymakers ◽  
Marco van Vulpen ◽  
Bernard A. Zonnenberg ◽  
J.L.H. Ruud Bosch ◽  
...  

2017 ◽  
Vol 8 (3) ◽  
pp. 357-363 ◽  
Author(s):  
Giovanni Mauri ◽  
L. Nicosia ◽  
G. M. Varano ◽  
G. Bonomo ◽  
P. Della Vigna ◽  
...  

2004 ◽  
Vol 71 (3) ◽  
pp. 187-190
Author(s):  
V. Alfano ◽  
C. Maganja ◽  
C. Tallarigo

2009 ◽  
Vol 9 (Special Issue A) ◽  
pp. S68-S70 ◽  
Author(s):  
Alice Gillams
Keyword(s):  

Author(s):  
Sachin Malde ◽  
Sarika Grover ◽  
Siddarth Raj ◽  
Cathy Yuan ◽  
Rajesh Nair ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document